全文获取类型
收费全文 | 108026篇 |
免费 | 10907篇 |
国内免费 | 3352篇 |
专业分类
耳鼻咽喉 | 750篇 |
儿科学 | 1729篇 |
妇产科学 | 1218篇 |
基础医学 | 20158篇 |
口腔科学 | 2859篇 |
临床医学 | 6764篇 |
内科学 | 16320篇 |
皮肤病学 | 1916篇 |
神经病学 | 11491篇 |
特种医学 | 2878篇 |
外国民族医学 | 27篇 |
外科学 | 8609篇 |
综合类 | 10640篇 |
现状与发展 | 14篇 |
预防医学 | 4410篇 |
眼科学 | 1095篇 |
药学 | 17260篇 |
34篇 | |
中国医学 | 4094篇 |
肿瘤学 | 10019篇 |
出版年
2024年 | 318篇 |
2023年 | 1959篇 |
2022年 | 4387篇 |
2021年 | 4971篇 |
2020年 | 4200篇 |
2019年 | 4481篇 |
2018年 | 4282篇 |
2017年 | 4212篇 |
2016年 | 3946篇 |
2015年 | 4466篇 |
2014年 | 6477篇 |
2013年 | 6728篇 |
2012年 | 5947篇 |
2011年 | 7101篇 |
2010年 | 5703篇 |
2009年 | 5711篇 |
2008年 | 5647篇 |
2007年 | 4800篇 |
2006年 | 4112篇 |
2005年 | 3806篇 |
2004年 | 3211篇 |
2003年 | 2851篇 |
2002年 | 2139篇 |
2001年 | 1806篇 |
2000年 | 1513篇 |
1999年 | 1411篇 |
1998年 | 1355篇 |
1997年 | 1320篇 |
1996年 | 1212篇 |
1995年 | 1110篇 |
1994年 | 1024篇 |
1993年 | 970篇 |
1992年 | 763篇 |
1991年 | 686篇 |
1990年 | 587篇 |
1989年 | 498篇 |
1988年 | 474篇 |
1987年 | 475篇 |
1986年 | 572篇 |
1985年 | 787篇 |
1984年 | 747篇 |
1983年 | 586篇 |
1982年 | 586篇 |
1981年 | 491篇 |
1980年 | 454篇 |
1979年 | 378篇 |
1978年 | 230篇 |
1977年 | 192篇 |
1976年 | 200篇 |
1975年 | 121篇 |
排序方式: 共有10000条查询结果,搜索用时 16 毫秒
101.
Prof. K. Loeschke MD B. Ueberschaer MD A. Pietsch E. Gruber MD K. Ewe MD B. Wiebecke MD W. Heldwein MD R. Lorenz MD 《Digestive diseases and sciences》1996,41(10):2087-2094
Relapse prevention by dietary n-3 fatty acids (5.1 g/day) was studied in a double-blind, placebo-controlled trial of 64 patients with ulcerative colitis in remission and off steroids. 5-ASA compounds were stopped three months after randomization and clinical disease activity monitored for two years. Macroscopic and histologic activity and extension was assessed by colonoscopy at entry and at exit. Both treatment groups were well matched at start. Nine patients on placebo and eight on n-3 fatty acids stopped taking their medication prematurely. Actuarial relapse-free survival was improved by n-3 fatty acids only during months 2 and 3 (2P<0.05–0.01), but cumulative relapse rate at two years was similar for those taking placebo (18/33=55%) and n-3 fatty acids (18/31=58%). There was also no consistent difference in clinical, macroscopic, and histologic disease activity between treatment groups. The n-3 fatty acids temporarily retard, but do not prevent, relapse of ulcerative colitis. 相似文献
102.
L. G. Ermilov S. M. Miller P. F. Schmalz M. Hanani§ V. A. Lennon‡ & J. H. Szurszewski† 《Neurogastroenterology and motility》2003,15(3):289-298
Intestinofugal afferent neurones (IFANs) provide excitatory synaptic input to abdominal prevertebral ganglion neurones. Input is greatly reduced during blockade of nicotinic acetylcholine receptors (nAChRs) in the wall of the colon, suggesting two projection pathways: a direct pathway without synaptic interruption and an indirect pathway interrupted by at least one nicotinic cholinergic synapse. This study aimed to characterize the morphology of IFANs and examine the distribution of nAChRs on them. We identified IFANs in guinea-pig colon by retrograde labelling with fluorescent tracer DiI placed either on the lumbar colonic nerves in vitro or inferior mesenteric ganglion in vivo. Confocal laser scanning microscopy and computerized image-processing software were used for 3D image reconstruction. Approximately 70% of identified IFANs had Dogiel type I-like morphology, the remainder were Dogiel type II-like. In vivo labelled IFANs were injected with Lucifer Yellow and immunostained for nAChRs using monoclonal antibody MAb35. Approximately 3% of total plasma membrane surface of IFANs with Dogiel type I morphology had MAb35-IR. In contrast, <1% of membrane surface of IFANs with Dogiel type II morphology had MAb35-IR. The finding that IFANs displayed immunostaining for nAChRs suggests the presence of putative nicotinic synapses. 相似文献
103.
J. N. Laverri re J. L. Richard A. Morin N. Buisson A. Tixier-Vidal W. B. Huttner D. Gourdji 《Molecular and cellular endocrinology》1991,80(1-3):41-51
Secretogranin I (SgI; chromogranin B) belongs to a class of acidic tyrosine-sulfated secretory proteins believed to play a role in the secretory process of endocrine cells. Our aim here was to compare the levels of SgI mRNA to that of prolactin (PRL) and growth hormone (GH), using rat pituitary cell lines. As far as the constitutive expression is concerned, we found a positive correlation between SgI mRNA and PRL mRNA levels. However, the neuropeptide TRH (50 nM) inhibited the accumulation of SgI mRNA in GH3B6 cells whereas, as expected, it induced a rapid and sustained increase in PRL mRNA accumulation. By contrast, 17β-estradiol (1 nM) stimulated the accumulation of both SgI and PRL mRNAs, with the same EC50 (18–59 pM). Reciprocally, treatment with dexamethasone (100 nM) reduced the level of SgI and PRL mRNAs to 23% and 29% of control, respectively, but led to a 2.1-fold increase in the GH mRNA level. Altogether, the present work shows that SgI gene expression is subject to multiple hormonal regulations and occasionally parallels the regulation of the PRL gene but never that of the GH gene, under the conditions tested. 相似文献
104.
Keratinocyte intercellular adhesion molecule (ICAM)-I expression is induced by interferon (IFN)-gamma. It has been previously reported that IFN-beta suppresses IFN-gamma-induced ICAM-I expression in A431 cells, a human squamous cell carcinoma cell line. In this study, the suppression mechanisms were investigated at the post second messenger level. Both 12-O-tetradecanoylphorbol-13-acetate (TPA) and calcium ionophore (A23187) induce ICAM-I expression in A431 cells. ICAM-I expression induced by either was not suppressed with cotreatment with IFN-beta. Furthermore, IFN-beta did not inhibit the translocation of protein kinase C (PKC) by TPA. It appears that the pathways involved in ICAM-I expression induced by activation of PKC or increased in intracellular Ca++ are not affected by IFN-beta. 相似文献
105.
N. BRUNELLO M. RIVA A. VOLTERRA and G. RACAGNI 《Fundamental & clinical pharmacology》1987,1(5):327-333
Chronic administration of different antidepressant drugs reduced the number of [3H]imipramine [( 3H]IMI) binding sites in rat cerebral cortex. In the same experimental conditions, fluvoxamine and dothiepin, as well as desmethylimipramine, induced an increase in the maximal velocity of high affinity serotonin (5HT) uptake in cortical slices, whereas citalopram and viloxazine were ineffective in this regard. Our results indicate that even if 5HT uptake and [3H]IMI binding sites are located on the same nerve terminals, they are differently modulated. Increased Vmax of the 5HT uptake process could be due to a rebound phenomenon after withdrawal from drugs that acutely inhibit 5HT uptake. The effect on [3H]IMI sites might be explained through either the agonist properties of the drugs towards these sites or the involvement of mechanisms still unknown. 相似文献
106.
The membrane potentials of astrocytes in primary cultures prepared from neonatal rat cerebral cortices were depolarized by (−)-norepinephrine. The average first response to 10−5 M (−)-norepinephrine was 24 mV from an average resting potential of −68 mV, and the average for the second response was 14 mV. Thus this process showed marked desensitization. The response was attributed to an activation of an α1-receptor since it was about 1000 times more sensitive to inhibition by prazosin than to yohimbine or idazoxan. In addition, depolarization was seen to the application of 10−5 M phenylephrine. 相似文献
107.
Juha-Matti Savola Michael Hill Mia Engstrom Hannele Merivuori Siegfried Wurster Steven G McGuire Susan H Fox Alan R Crossman Jonathan M Brotchie 《Movement disorders》2003,18(8):872-883
Previous studies in the MPTP-lesioned primate model of Parkinson's disease have demonstrated that alpha(2) adrenergic receptor antagonists such as idazoxan, rauwolscine, and yohimbine can alleviate L-dopa-induced dyskinesia and, in the case of idazoxan, enhance the duration of anti-parkinsonian action of L-dopa. Here we describe a novel alpha(2) antagonist, fipamezole (JP-1730), which has high affinity at human alpha(2A) (K(i), 9.2 nM), alpha(2B) (17 nM), and alpha(2C) (55 nM) receptors. In functional assays, the potent antagonist properties of JP-1730 were demonstrated by its ability to reduce adrenaline-induced (35)S-GTPgammaS binding with K(B) values of 8.4 nM, 16 nM, 4.7 nM at human alpha(2A), alpha(2B), and alpha(2C) receptors, respectively. Assessment of the ability of JP-1730 to bind to a range of 30 other binding sites showed that JP-1730 also had moderate affinity at histamine H1 and H3 receptors and the serotonin (5-HT) transporter (IC(50) 100 nM to 1 microM). In the MPTP-lesioned marmoset, JP-1730 (10 mg/kg) significantly reduced L-dopa-induced dyskinesia without compromising the anti-parkinsonian action of L-dopa. The duration of action of the combination of L-dopa and JP-1730 (10 mg/kg) was 66% greater than that of L-dopa alone. These data suggest that JP-1730 is a potent alpha(2) adrenergic receptor antagonist with potential as an anti-dyskinetic agent in the treatment of Parkinson's disease. 相似文献
108.
Oded Gonen Afsaneh Mohebbi Radka Stoyanova Truman R. Brown 《Magnetic resonance in medicine》1997,37(2):301-306
Refocused insensitive nucleus enhancement by polarization transfer (RINEPT) from protons (1H) to a J-coupled phosphorus (31P) has been incorporated into three-dimensional (3D) chemical-shift-imaging (CSI) sequence on a clinical imager. The technique is demonstrated on a phantom and in in vivo human brain. The polarization-transfer efficiency (~1.2) is lower than the theoretical maximum of γ1H/γ31P≈ 2.4 resulting from 1H-1H homonuclear J couplings of similar magnitude competing with the 1H →31P transfer. Nevertheless, compared with direct 31P Ernst-angle excitation, signal gains of up to × 1.8 were obtained mainly as a result of T1 differences between 31P and the 1H. Spectral interpretation is simplified by editing out all non-proton-coupled 31P signals. The duration, ~50 min, and power deposition, ~1 W · kg?1, make the application suitable for human studies. 相似文献
109.
J. D. Martins J. P. Monteiro M. C. Antunes-Madeira A. S. Jurado V. M. C. Madeira 《Toxicology in vitro》2003,17(5-6):595
Microorganisms are very powerful tools for the supply of information about the toxic effects of lipophilic compounds, since an impairment of cell growth usually occurs as a result of perturbations related, in most cases, with the partition of toxicants in membranes. The thermophilic eubacterium Bacillus stearothermophilus has been used as a model system to identify α- and β-endosulfan interactions with the membrane possibly related with the insecticide toxicity. Two approaches have been pursued: (a) bacterial growth is followed and the effects of endosulfan isomers determined; (b) biophysical studies with the fluorescent fluidity probe 1,6-diphenyl-1,3,5-hexatriene (DPH) were performed to assess the effects of α- and β-endosulfan on the organization of the membrane lipid bilayer. The effects on growth were quantitatively evaluated by determination of growth parameters, namely the lag phase, the specific growth rate and the cell density reached by cultures in the stationary phase. Growth inhibition by α and β-endosulfan dependent on the concentration is diminished or removed by the addition of 2.5 m
Ca2+ to bacterial cultures. Fluorescence DPH polarization consistently showed opposite effects of Ca2+ and α- and β-endosulfan on the physical state of bacterial polar lipid dispersions. 相似文献
110.